(Q37828059)

23 August 2017

1 reference

title

The role of oxidative stress in the pathophysiology of hypertension (English)

1 reference

23 August 2017

main subject

arterial hypertension

0 references

1 reference

0 references

Ramón Rodrigo

1

1 reference

23 August 2017

Jaime González

series ordinal

2

1 reference

23 August 2017

Fabio Paoletto

series ordinal

3

1 reference

23 August 2017

publication date

13 January 2011

1 reference

23 August 2017

published in

Hypertension Research

1 reference

23 August 2017

volume

34

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

431-440

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2010.264

23 August 2017

exact match

0 references

cites work

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Redox signaling in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Implications of Oxidative Stress and Homocysteine in the Pathophysiology of Essential Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Redox control of calcium channels: from mechanisms to therapeutic opportunities.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Role of thioredoxin in cell growth through interactions with signaling molecules

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Antioxidant Activities and Oxidative Stress Byproducts in Human Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Oxidative stress and hypertension: current concepts

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Relationship between oxidative stress and essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Decreased blood pressure in NOX1-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Different effect of antihypertensive drugs on conduit artery endothelial function

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Exercise training, NADPH oxidase p22phox gene polymorphisms, and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Vascular NAD(P)H oxidases: specific features, expression, and regulation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Renal xanthine oxidoreductase activity during development of hypertension in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Succinate-dependent lipid peroxidation and its prevention by reduced ubiquinone in beef heart submitochondrial particles

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Reduction in extracellular superoxide dismutase activity in African-American patients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

S-Nitrosothiols: cellular formation and transport

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Angiotensin II and oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Reactive oxygen species in the vasculature: molecular and cellular mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Interactions between vasoconstrictors and vasodilators in regulating hemodynamics of distinct vascular beds

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Localization of the urotensin II receptor in the rat central nervous system.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Homocysteine and Essential Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Oxidative stress and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Renal damage mediated by oxidative stress: a hypothesis of protective effects of red wine

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Redox signaling via lipid raft clustering in homocysteine-induced injury of podocytes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Urinary tract obstruction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Angiotensin II-induced reactive oxygen species and the kidney

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Metabolic syndrome and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Mechanism of endothelial dysfunction in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Oxidative stress and endothelial dysfunction in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

The sympathetic control of blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Oxidative stress and central cardiovascular regulation. - Pathogenesis of hypertension and therapeutic aspects -.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Reactive oxygen molecules, oxidant injury and renal disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

https://api.crossref.org/works/10.1038%2FHR.2010.264

1 reference

7 January 2021

Eicosonoid metabolism and beta-adrenergic mechanisms in coronary arterial smooth muscle: potential compartmentation of cAMP

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Glutathione system in young spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Vascular structure and oxidative stress in salt-loaded spontaneously hypertensive rats: effects of losartan and atenolol

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Different antioxidants status, total antioxidant power and free radicals in essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Superoxide dismutase, catalase and glutathione peroxidase in the spontaneously hypertensive rat kidney: effect of antioxidant-rich diet

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Modulation of endogenous glutathione availability

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Renal glutathione S-transferase mu type 1 expression is already reduced in new-born spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Thioredoxin in vascular biology: role in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Endothelial cells negatively modulate reactive oxygen species generation in vascular smooth muscle cells: role of thioredoxin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Thioredoxin in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Bilirubin chemistry and metabolism; harmful and protective aspects.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Moderate hyperbilirubinemia improves renal hemodynamics in ANG II-dependent hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Bilirubin exerts renoprotective effects in angiotensin II-hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

The bilirubin level is negatively correlated with the incidence of hypertension in normotensive Korean population

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Uric acid reduces exercise-induced oxidative stress in healthy adults

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Uric acid and hypertension: cause or effect?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Update on gout and hyperuricemia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Effects of vitamin C on high blood pressure induced by salt in spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Ascorbate Prevents the Interaction of Superoxide and Nitric Oxide Only at Very High Physiological Concentrations

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Treatment of hypertension with ascorbic acid

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Ascorbic acid status and subsequent diastolic and systolic blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

A double-blind, placebo-controlled parallel trial of vitamin C treatment in elderly patients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Combination oral antioxidant supplementation reduces blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Protection against reactive oxygen species by selenoproteins

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Vitamin C as an antioxidant: evaluation of its role in disease prevention

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Are ACE inhibitors a "magic bullet" against oxidative stress?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Alpha-Tocopherol and endothelial nitric oxide synthesis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Current concepts in the use of antioxidants for the treatment of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Clinical pharmacology and therapeutic use of antioxidant vitamins

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Microvascular display of xanthine oxidase and NADPH oxidase in the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

The role of urate and xanthine oxidase in vascular oxidative stress: future directions

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Inhibition of NF-kappaB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Selenium and sulforaphane modify the expression of selenoenzymes in the human endothelial cell line EAhy926 and protect cells from oxidative damage

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Paraquat-induced oxidative stress and dysfunction of cellular redox systems including antioxidative defense enzymes glutathione peroxidase and thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Protective effects of antioxidant micronutrients (vitamin E, zinc and selenium) in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Selenium-dependent enzymes in endothelial cell function

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Enhancement of endogenous defenses against ROS by supra-nutritional level of selenium is more safe and effective than antioxidant supplementation in reducing hypertensive target organ damage

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Effect of dietary selenium on the progression of heart failure in the ageing spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Reduced selenium concentrations and glutathione peroxidase activity in preeclamptic pregnancies

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Blood pressure and blood selenium: a cross-sectional and longitudinal population study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Ascorbic acid and N-acetylcysteine improve in vitro the function of lymphocytes from mice with endotoxin-induced oxidative stress.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Oxidative stress and protective effects of polyphenols: comparative studies in human and rodent kidney. A review

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Fruit and vegetable consumption is inversely associated with blood pressure in a Mediterranean population with a high vegetable-fat intake: the Seguimiento Universidad de Navarra (SUN) Study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

The effect of nutrition on blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Low-sodium Dietary Approaches to Stop Hypertension-type diet including lean red meat lowers blood pressure in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

The effect of dietary patterns on estimated coronary heart disease risk: results from the Dietary Approaches to Stop Hypertension (DASH) trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79 years

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.264

7 January 2021

Identifiers

DOI

10.1038/HR.2010.264

1 reference

23 August 2017

1 reference